Caligan Partners LP
data from 31/03/2026
Capitalization
Portfolio size
Portfolio performance
Portfolio performance %
Performance compared to S&P 500 (%)
Stock in Caligan Partners LP
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2026/03/31 | LQDA | LIQUIDIA CORPORATION | 20.39% | 306.407 M $ | 8118892 | 2022/12/31 | 26.386 M $ | 9.42 % |
| 2026/03/31 | ABVX | ABIVAX SA | 10.83% | 162.785 M $ | 1461924 | 2024/12/31 | -34.120 M $ | -17.43 % |
| 2026/03/31 | RVMD | REVOLUTION MEDICINES INC | 10.70% | 160.736 M $ | 1652808 | 2025/03/31 | 22.597 M $ | 22.10 % |
| 2026/03/31 | PCVX | VAXCYTE INC | 7.97% | 119.748 M $ | 2060719 | 2025/12/31 | 20.407 M $ | 25.94 % |
| 2026/03/31 | XENE | XENON PHARMACEUTICALS INC | 5.39% | 81.005 M $ | 1393027 | 2025/09/30 | 7.327 M $ | 29.74 % |
| 2026/03/31 | MLYS | MINERALYS THERAPEUTICS INC | 5.00% | 75.111 M $ | 2772654 | 2024/06/30 | -25.508 M $ | -25.35 % |
| 2026/03/31 | EXEL | EXELIXIS INC | 4.43% | 66.619 M $ | 1553262 | 2023/03/31 | -1.460 M $ | -2.14 % |
| 2026/03/31 | CGON | CG ONCOLOGY INC | 4.05% | 60.912 M $ | 900000 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | TNGX | TANGO THERAPEUTICS INC | 3.35% | 50.392 M $ | 2408798 | 2025/12/31 | 44.983 M $ | 136.12 % |
| 2026/03/31 | TYRA | TYRA BIOSCIENCES INC | 3.25% | 48.908 M $ | 1276968 | 2025/03/31 | 11.341 M $ | 45.68 % |
| 2026/03/31 | SYRE | SPYRE THERAPEUTICS INC | 2.95% | 44.293 M $ | 878127 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | ADMA | ADMA BIOLOGICS INC | 2.85% | 42.856 M $ | 4756511 | 2025/09/30 | -27.805 M $ | -50.60 % |
| 2026/03/31 | LBRX | LB PHARMACEUTICALS INC | 2.30% | 34.629 M $ | 1438070 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | VOR | VOR BIOPHARMA INC | 2.29% | 34.343 M $ | 1925066 | 2025/12/31 | 4.403 M $ | 44.20 % |
| 2026/03/31 | SABS | SAB BIOTHERAPEUTICS INC | 2.03% | 30.514 M $ | 7967207 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | OPUS GENETICS INC | 1.84% | 27.641 M $ | 6075028 | 2026/03/31 | 0.000 $ | 0.00 % | |
| 2026/03/31 | IVA | INVENTIVA SA | 1.84% | 27.611 M $ | 4974906 | 2025/12/31 | 1.800 M $ | 19.35 % |
| 2026/03/31 | MBX | MBX BIOSCIENCES INC | 1.69% | 25.330 M $ | 848590 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | AVTX | AVALO THERAPEUTICS INC | 1.62% | 24.411 M $ | 1635023 | 2025/09/30 | -2.847 M $ | -17.79 % |
| 2026/03/31 | RVMD | REVOLUTION MEDICINES INC | 1.48% | 22.261 M $ | 228900 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | ANIK | ANIKA THERAPEUTICS INC | 1.38% | 20.809 M $ | 1435130 | 2022/12/31 | 7.018 M $ | 50.88 % |
| 2026/03/31 | MAZE | MAZE THERAPEUTICS INC | 1.22% | 18.357 M $ | 614962 | 2025/12/31 | -6.371 M $ | -27.95 % |
| 2026/03/31 | VRCA | VERRICA PHARMACEUTICALS INC | 0.33% | 4.887 M $ | 923910 | 2025/09/30 | -2.790 M $ | -36.34 % |
| 2026/03/31 | SNSE | SENSEI BIOTHERAPEUTICS INC | 0.26% | 3.972 M $ | 126002 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | AGIO | AGIOS PHARMACEUTICALS INC | 0.20% | 3.045 M $ | 90000 | 2025/12/31 | 594.900 K $ | 24.28 % |
| 2026/03/31 | ADMA | ADMA BIOLOGICS INC | 0.18% | 2.703 M $ | 300000 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | AURA | AURA BIOSCIENCES INC | 0.10% | 1.538 M $ | 229864 | 2025/06/30 | 0.000 $ | 0.00 % |
| 2026/03/31 | XLO | XILIO THERAPEUTICS INC | 0.06% | 942.996 K $ | 112128 | 2026/03/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | XENE | XENON PHARMACEUTICALS INC | 0.00% | 0.000 $ | 0 | 2025/12/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | SPRB | SPRUCE BIOSCIENCES INC | 0.00% | 0.000 $ | 0 | 2025/12/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | ELDN | ELEDON PHARMACEUTICALS INC | 0.00% | 0.000 $ | 0 | 2025/12/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | INBX | INHIBRX BIOSCIENCES INC | 0.00% | 0.000 $ | 0 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2026/03/31 | INBX | INHIBRX BIOSCIENCES INC | 0.00% | 0.000 $ | 0 | 2025/12/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | MLYS | MINERALYS THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2025/12/31 | 0.000 $ | 0.00 % |
| 2026/03/31 | RAPT | RAPT THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2025/12/31 | 0.000 $ | 0.00 % |